Suche klinische Studie
Weitere Suchoptionen
30 Ergebnis(se)
Rekrutierende Studie = 
; Fortlaufende Studie = 
; Abgeschlossene Studie = 
; Förderung durch ein IRDiRC-Mitglied = 
; Studie unter Beteiligung von ERN-Mitgliedern aus mindestens zwei Mitgliedstaaten = 
Nationale klinische Studie(n)
DEUTSCHLAND
Berlin
ADDRESS: NOT PROVIDED - DE
ADDRESS+: Eine offene, multizentrische Follow-up-Studie mit ARGX-113-1904 zur Bewertung der Sicherheit, Verträglichkeit und Wirksamkeit von Efgartigimod PH20 SC bei Patienten mit Pemphigus
Institution: Information not provided - DE
DEUTSCHLAND
Berlin
ADDRESS: NOT PROVIDED - DE
ADDRESS: Eine randomisierte, doppelblinde, placebokontrollierte Studie zur Untersuchung der Wirksamkeit, Sicherheit und Verträglichkeit von Efgartigimod PH20 SC bei erwachsenen Patienten mit Pemphigus
Institution: Information not provided - DE
DEUTSCHLAND
Berlin
ADDRESS: NOT PROVIDED - DE
LIBERTY-BP: Eine multizentrische, randomisierte, doppelblinde, placebokontrollierte, parallele Gruppenstudie zur Bewertung der Wirksamkeit und Sicherheit von Dupilumab bei erwachsenen Patienten mit bullösem Pemphigoid
Institution: Information not provided - DE
DEUTSCHLAND
Berlin
ADDRESS: NOT PROVIDED - DE
BALLAD: Eine randomisierte, doppelblinde, placebokontrollierte Parallelgruppenstudie der Phase 2/3 zur Untersuchung der Wirksamkeit und Sicherheit von Efgartigimod PH20 SC bei erwachsenen Teilnehmern mit bullösem Pemphigoid
Institution: Information not provided - DE
DEUTSCHLAND
Berlin
ADDRESS: NOT PROVIDED - DE
FJORD: Eine multinationale, randomisierte, doppelblinde, placebokontrollierte Parallelgruppenstudie zur Untersuchung der Verwendung von Benralizumab als Behandlungsoption für Patienten mit bullösem Pemphigoid
Institution: Information not provided - DE
DEUTSCHLAND
Hessen
MARBURG
TPV11: Multizentrische, offene Phase-1-Studie, Teil A mit Einzeldosen in aufsteigenden Konzentrationen, Teil B mit Mehrfachdosen, zur Bewertung der Sicherheit, Verträglichkeit und Pharmakokinetik und zur Untersuchung früher Anzeichen der Wirksamkeit bei der Induktion der antigenspezifischen Immuntoleranz durch TPM203 bei Patienten mit Pemphigus vulgaris (PEGASUS: SP 8)
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Dermatologie und Allergologie
FRANKREICH
HAUTS-DE-FRANCE
ADDRESS: NOT PROVIDED - FR
A randomized, double-blind, double-dummy active-comparator, multicenter study to evaluate the efficacy and safety of rituximab versus MMF in patients with pemphigus vulgaris -FR
Institution: Information not provided - FR
FRANKREICH
HAUTS-DE-FRANCE
ADDRESS: NOT PROVIDED - FR
ADDRESS: A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus) -FR
Institution: Information not provided - FR
FRANKREICH
ILE-DE-FRANCE
BOBIGNY
An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904 to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Pemphigus (ADDRESS PLUS) - ARGX-113-1905 -FR
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de Dermatologie
FRANKREICH
ILE-DE-FRANCE
BOBIGNY
LIBERTY-BP: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients with Bullous Pemphigoid - FR
CHU Paris Seine-Saint-Denis - Hôpital Avicenne
Service de Dermatologie
FRANKREICH
NORMANDIE
ROUEN
RITUX-MMP : Randomized Double Blind Double Dummy Control Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid (Phase III)
CHU de Rouen
Clinique dermatologique
FRANKREICH
NOUVELLE AQUITAINE
BORDEAUX
PEMPA : Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid (Phase III)
CHU de Bordeaux - Hôpital Saint André
Service de Dermatologie adulte et pédiatrique
FRANKREICH
PROVENCE-ALPES-COTE D'AZUR
NICE
Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody - FR
CHU de Nice - Hôpital l'Archet 2
Service de Dermatologie - Vénérologie
ITALIEN
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Oral BTK Inhibitor PRN1008 in Moderate to Severe Pemphigus - IT
Institution: Information not provided - IT
JAPAN
JAPAN
ADDRESS : NOT PROVIDED - JP
A Randomized, Double-Blinded, Placebo-Controlled Trial of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus) (ADDRESS)
Institution: Information not provided - JP
JAPAN
JAPAN
ADDRESS : NOT PROVIDED - JP
Open-label follow-up trial of ARGX-113-1904 (ADDRESS+)
Institution: Information not provided - JP
SPANIEN
Galicia
SANTIAGO DE COMPOSTELA
A Long-Term Follow-up Study to Evaluate the Safety and Efficacy of Adeno-Associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Glucose-6-Phosphatase (G6Pase) in Adults with Glycogen Storage Disease Type Ia (GSDIa) -ES
Complejo Hospitalario Universitario de Santiago
Servicio de Pediatría
SPANIEN
Madrid
ADDRESS: NOT PROVIDED - ES
ADDRESS+: An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1905 to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Pemphigus (ADDRESS PLUS) - ARGX-113-1905 -ES
Institution: Information not provided - ES
SPANIEN
Madrid
ADDRESS: NOT PROVIDED - ES
ADDRESS: A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus) -ES
Institution: Information not provided - ES
SPANIEN
Madrid
ADDRESS: NOT PROVIDED - ES
FJORD: A Multinational, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Investigate the Use of Benralizumab as a Treatment Option for Patients with Bullous Pemphigoid -ES
Institution: Information not provided - ES
SPANIEN
Madrid
ADDRESS: NOT PROVIDED - ES
CELOPHIN: Phase IIa multicenter clinical trial to determine the feasibility and safety of the use of adipose-derived mesenchymal stem cells (ASC) in the treatment of patients with cicatricial conjunctivitis associated with Lyell's syndrome, Stevens-Johnson syndrome and pemphigoid of the mucous membranes with ocular involvement - ES
Institution: Information not provided - ES
SPANIEN
Madrid
ADDRESS: NOT PROVIDED - ES
BALLAD: A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid -ES
Institution: Information not provided - ES
SPANIEN
Madrid
ADDRESS: NOT PROVIDED - ES
BALLAD+: An Open-label Extension Study of ARGX-113-2009 to Evaluate the Long term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid - ES
Institution: Information not provided - ES
SPANIEN
Madrid
ADDRESS: NOT PROVIDED - ES
LIBERTY-BP: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients with Bullous Pemphigoid - ES
Institution: Information not provided - ES
Multinationale klinische Studie(n)
SCHWEIZ
Suisse Romande
ADDRESS: NOT PROVIDED - CH
PEMPHIX: A randomized, double-blind, double-dummy active-comparator, multicenter study to evaluate the efficacy and safety of rituximab versus MMF in patients with pemphigus vulgaris (Phase III)
Institution: Information not provided - CH
VEREINIGTE STAATEN
California
SOUTH SAN FRANCISCO
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Oral BTK Inhibitor PRN1008 in Moderate to Severe Pemphigus
Principia Biopharma
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
A Randomized, Double-blind, Placebo Controlled, Parallel Group Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of QGE031 in the Treatment of Patients With Bullous Pemphigoid With Disease Refractory to Oral Steroid Treatment
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
ADDRESS: A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus)
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
ADDRESS PLUS: An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904 to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Pemphigus - ARGX-113-1904
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US